This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-11 March 2022, and includes updates on COVID-19, rat hepatitis E, seasonal influenza, measles, Japanese encephalitis, polio, MERS-CoV, dengue, chikungunya and the influx of people displaced from Ukraine to the EU following Russia's invasion of Ukraine.
For 2019, 30 EU/EEA Member States reported 29 996 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 29 518, corresponds to a crude rate of 7.4 cases per 100 000 population.
In 2019, 37 733 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases leaves 37 660 cases, which corresponds to a crude rate of 8.9 cases per 100 000 population.
This study provides insights for national public health authorities into the factors behind the spread of vaccine misinformation online and the options and capacities needed for responding to it.
In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.